Effects of doxapram in dogs given atropine and xylazine.
Hatch
R C
RC
D015761:4-Aminopyridine / Q000494:pharmacology; D000759:Adjuvants, Anesthesia / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D000818:Animals; D001285:Atropine / Q000008:administration & dosage; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000494:pharmacology*; D004285:Dogs / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D004315:Doxapram / Q000009:adverse effects / Q000494:pharmacology*; D016896:Treatment Outcome; D014991:Xylazine / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D015016:Yohimbine / Q000494:pharmacology
D000759:Adjuvants, Anesthesia; D000697:Central Nervous System Stimulants; D014991:Xylazine; D015016:Yohimbine; D001285:Atropine; D004315:Doxapram; D015761:4-Aminopyridine